D. H. Silberberg

3.3k total citations · 1 hit paper
46 papers, 2.5k citations indexed

About

D. H. Silberberg is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, D. H. Silberberg has authored 46 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 13 papers in Molecular Biology and 7 papers in Clinical Biochemistry. Recurrent topics in D. H. Silberberg's work include Multiple Sclerosis Research Studies (12 papers), Metabolism and Genetic Disorders (7 papers) and Neurogenesis and neuroplasticity mechanisms (7 papers). D. H. Silberberg is often cited by papers focused on Multiple Sclerosis Research Studies (12 papers), Metabolism and Genetic Disorders (7 papers) and Neurogenesis and neuroplasticity mechanisms (7 papers). D. H. Silberberg collaborates with scholars based in United States, Switzerland and United Kingdom. D. H. Silberberg's co-authors include Francisco González‐Scarano, Robert I. Grossman, William Likosky, Fred Lublin, W. H. Stuart, Stanley van den Noort, Gerald Garmany, Douglas S. Goodin, June Halper and Shama Bhat and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

D. H. Silberberg

46 papers receiving 2.3k citations

Hit Papers

Disease modifying therapies in multiple sclerosis: Subcom... 2002 2026 2010 2018 2002 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]
    2002 603 citations Douglas S. Goodin, Gerald Garmany et al. Neurology profile →

Peers

D. H. Silberberg
Geoffrey Keir United Kingdom
George W. Ellison United States
M. K. Sharief United Kingdom
Magnus Vrethem Sweden
E J Thompson United Kingdom
Ayman Tourbah France
G Ponsot France
Kenneth G. Warren Canada
John King Australia
K. P. Johnson United States
Geoffrey Keir United Kingdom
D. H. Silberberg
Citations per year, relative to D. H. Silberberg D. H. Silberberg (= 1×) peers Geoffrey Keir

Countries citing papers authored by D. H. Silberberg

Since Specialization
Citations

This map shows the geographic impact of D. H. Silberberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. H. Silberberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. H. Silberberg more than expected).

Fields of papers citing papers by D. H. Silberberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. H. Silberberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. H. Silberberg. The network helps show where D. H. Silberberg may publish in the future.

Co-authorship network of co-authors of D. H. Silberberg

This figure shows the co-authorship network connecting the top 25 collaborators of D. H. Silberberg. A scholar is included among the top collaborators of D. H. Silberberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. H. Silberberg. D. H. Silberberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goodin, Douglas S., Gerald Garmany, June Halper, et al.. (2002). Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]. Neurology. 58(2). 169–178. 603 indexed citations breakdown →
2.
Ellenberg, Jonas H., et al.. (1992). Revised estimate of the prevalence of multiple sclerosis in the united states. Annals of Neurology. 31(3). 333–336. 236 indexed citations
3.
4.
Grossman, Robert I., B. Braffman, James R. Brorson, et al.. (1988). Multiple sclerosis: serial study of gadolinium-enhanced MR imaging.. Radiology. 169(1). 117–122. 140 indexed citations
5.
Bhat, Shama & D. H. Silberberg. (1988). NCAM-180, the largest component of the neural cell adhesion molecule, is reduced in dysmyelinating quaking mutant mouse brain. Brain Research. 452(1-2). 373–377. 13 indexed citations
6.
Lavi, Ehud, Akio Suzumura, Donna M. Murasko, et al.. (1988). Tumor Necrosis Factor Induces Expression of MHC Class I Antigens on Mouse Astrocytes. Annals of the New York Academy of Sciences. 540(1). 488–490. 22 indexed citations
7.
Silberberg, D. H., et al.. (1988). Azathioprine in multiple sclerosis: the cons.. PubMed. 38(1). 24–7. 62 indexed citations
8.
Rostami, A M, James B. Burns, P. Ann Eccleston, et al.. (1987). Search for antibodies to galactocerebroside in the serum and cerebrospinal fluid in human demyelinating disorders. Annals of Neurology. 22(3). 381–383. 28 indexed citations
9.
10.
Bhat, Sushant & D. H. Silberberg. (1986). Oligodendrocyte cell adhesion molecules are related to neural cell adhesion molecule (N-CAM). Journal of Neuroscience. 6(11). 3348–3354. 42 indexed citations
11.
Saida, Kyoko, Takahiko Saida, Mark J. Brown, D. H. Silberberg, & Arthur K. Asbury. (1978). Antiserum-mediated demyelination in vivo: a sequential study using intraneural injection of experimental allergic neuritis serum.. PubMed. 39(5). 449–62. 83 indexed citations
12.
Dupont, Bo, C Jersild, John A. Hansen, et al.. (1977). HLA antigens in black American patients with multiple sclerosis.. PubMed. 9(1 Suppl 1). 181–5. 19 indexed citations
13.
Lisak, Robert P., et al.. (1977). Antimyelin antibody in multiple sclerosis: no change during immunosuppression. Journal of Neurology Neurosurgery & Psychiatry. 40(9). 872–875. 4 indexed citations
14.
Silberberg, D. H., Charles R. Sanders, Oded Abramsky, & Takahiko Saida. (1977). SCANNING ELECTRON MICROSCOPT OBSERVATIONS OF ISOLATED OLIGODENDROCYTES. Journal of Neuropathology & Experimental Neurology. 36(3). 630–630. 2 indexed citations
15.
Saida, Takahiko, D. H. Silberberg, June M. Fry, & Margaret C. Manning. (1977). DEMYELINATING ANTI-GALACIOCEREBROSIDE ANTIBODIES IN EAN AND EAE. Journal of Neuropathology & Experimental Neurology. 36(3). 627–627. 10 indexed citations
16.
Abramsky, Oded, et al.. (1977). Antibodies to Oligodendroglia in Patients with Multiple Sclerosis. New England Journal of Medicine. 297(22). 1207–1211. 126 indexed citations
17.
Silberberg, D. H. & Alan M. Laties. (1973). Increased Intracranial Pressure in Disseminated Lupus Erythematosus. Archives of Neurology. 29(2). 88–90. 34 indexed citations
18.
Silberberg, D. H., et al.. (1970). Photodegradation products of bilirubin studied in myelinating cerebellum cultures.. PubMed. 6(2). 119–23. 2 indexed citations
19.
Silberberg, D. H.. (1969). MAPLE SYRUP URINE DISEASE METABOLITES STUDIED IN CEREBELLUM CULTURES1. Journal of Neurochemistry. 16(7). 1141–1146. 31 indexed citations
20.
Silberberg, D. H.. (1967). Phenylketonuria Metabolites in Cerebellum Culture Morphology. Archives of Neurology. 17(5). 524–529. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geoffrey Keir Breakdown of academic impact, for papers by George W. Ellison Breakdown of academic impact, for papers by M. K. Sharief Breakdown of academic impact, for papers by Magnus Vrethem Breakdown of academic impact, for papers by E J Thompson Breakdown of academic impact, for papers by Ayman Tourbah Breakdown of academic impact, for papers by G Ponsot Breakdown of academic impact, for papers by Kenneth G. Warren Breakdown of academic impact, for papers by John King Breakdown of academic impact, for papers by K. P. Johnson
Rankless by CCL
2026